biotech news today obesity drugs glp-1 The race may have a new contender. 👋 Regeneron reported Phase 3 data showing its drug candidate delivered up to 19.3% weight loss at 48 weeks, approaching the efficacy seen GLP-1s and the Unintended Consequences

Injectable GLP-1 RAs like liraglutide, semaglutide, and dulaglutide have been shown to significantly lower HbA1c and body weight in patients with T2DM

[DOI] [PMC free article] [PubMed] [Google Scholar] 148

Effects on liver Despite the lack of expression of GIPR (41, 191) and GLP-1R (192, 193) in hepatocytes, both GIP and GLP-1 have indirect effects on hepatic lipid and glucose metabolism (194)

He explained that weight gain causes irregular menstruation a common issue in PCOS and therefore, it can lead to reduced reproductive ability

It helps regulate blood sugar, digestion, and appetite

These fats are also great for supporting your overall health